1,3-substituted pyrazole compounds useful for reduction of very long chain fatty acid levels

Disclosed are chemical entities which are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein Formula (I) has the structure, (I), wherein: R1a, R1b, R2, R3, R4a, R4b and Y are as defined herein. These chemical entities are useful for reduction of very long chain fatty aci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GU, WENXIN, NANTHAKUMAR, SUGANTHINI S, GALE-DAY, ZACHARY, RONKIN, STEVEN MICHAEL, JACKSON, KATRINA L, MAGAVI, SANJAY SHIVAYOGI, CHARIFSON, PAUL S, SWETT, REBECCA JANE, COURT, JOHN J, TANG, QING, COME, JON H
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed are chemical entities which are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein Formula (I) has the structure, (I), wherein: R1a, R1b, R2, R3, R4a, R4b and Y are as defined herein. These chemical entities are useful for reduction of very long chain fatty acid levels. These chemical entities and pharmaceutically acceptable compositions comprising such chemical entities can be useful for treating various diseases, disorders and conditions, such as adrenoleukodystrophy (ALD).